Veeva Systems Rises as Product Momentum and Recent Results Support Shares
Investivoq PriceTracker
Veeva Systems (VEEV) is up 3.0% today. Here is some analysis on what might have caused this price movement.
Analysis: The move appears tied to continued optimism around Veeva’s clinical data and AI product momentum, alongside strong recent operating results. There does not appear to be a single fresh event directly tied to today’s gain, so part of the move could also be momentum buying as the stock trades near recent highs.
Details:
Sources:
Veeva Systems Investor Relations, SEC, StockAnalysis
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$VEEV Insider Trading Activity
$VEEV insiders have traded $VEEV stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $VEEV stock by insiders over the last 6 months:
- THOMAS D. SCHWENGER (Pres. & Chief Customer Officer) has made 0 purchases and 3 sales selling 16,000 shares for an estimated $4,078,500.
- DANIEL J RIZZO (EVP, Sales, Consulting, & Svcs) has made 0 purchases and 2 sales selling 4,841 shares for an estimated $1,338,578.
- PRISCILLA HUNG has made 0 purchases and 2 sales selling 1,500 shares for an estimated $312,510.
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$VEEV Hedge Fund Activity
We have seen 567 institutional investors add shares of $VEEV stock to their portfolio, and 500 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TIGER GLOBAL MANAGEMENT LLC removed 2,420,500 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $429,566,135
- FMR LLC removed 2,338,217 shares (-89.5%) from their portfolio in Q2 2026, for an estimated $414,963,370
- JPMORGAN CHASE & CO added 1,600,195 shares (+inf%) to their portfolio in Q2 2026, for an estimated $283,986,606
- ALLIANCEBERNSTEIN L.P. removed 1,357,776 shares (-21.7%) from their portfolio in Q2 2026, for an estimated $240,964,506
- INVESCO LTD. added 1,350,324 shares (+626.2%) to their portfolio in Q2 2026, for an estimated $239,642,000
- BLACKROCK, INC. added 1,303,628 shares (+11.3%) to their portfolio in Q2 2026, for an estimated $231,354,861
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,282,294 shares (+inf%) to their portfolio in Q2 2026, for an estimated $227,568,716
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$VEEV Analyst Ratings
Wall Street analysts have issued reports on $VEEV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 06/04/2026
- Needham issued a "Buy" rating on 06/04/2026
- Piper Sandler issued a "Overweight" rating on 06/04/2026
To track analyst ratings and price targets for $VEEV, check out Investivoq's $VEEV forecast page.
$VEEV Price Targets
Multiple analysts have issued price targets for $VEEV recently. We have seen 16 analysts offer price targets for $VEEV in the last 6 months, with a median target of $232.5.
Here are some recent targets:
- David Larsen from BTIG set a target price of $340.0 on 06/04/2026
- Saket Kalia from Barclays set a target price of $235.0 on 06/04/2026
- Ken Wong from Oppenheimer set a target price of $225.0 on 06/04/2026
- Gabriela Borges from Goldman Sachs set a target price of $165.0 on 06/04/2026
- Steven Valiquette from Mizuho set a target price of $270.0 on 06/04/2026
- Tyler Radke from Citigroup set a target price of $190.0 on 06/04/2026
- David Grossman from Stifel set a target price of $230.0 on 06/04/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.